TrialBritish journal of cancer2021

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Rupert Bartsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.